Immunomic Therapeutics, Inc.

Amendment
CIK: 0001543256·Biotechnology·DELAWARE·Filed: Jun 12, 2013
Total Offering

$2,000,000

Amount Sold

$1,617,000

Investors

60

First Sale

Aug 16, 2011

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
William G Hearl
Related Person
Bernard C Rudnick
Related Person
Lisa Salley
Related Person
Bruce Mackler
Related Person
Winston I Lowe
Related Person
James Wishart
Related Person
Ronald Thiboutot
Related Person
William Barry McDonald
Related Person

Company

Immunomic Therapeutics, Inc.

ATTN: WILLIAM HEARL, 313 W. LIBERTY ST.

LANCASTER, PA, 17603

717-327-1919

SEC Filing

0001543256-13-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Immunomic Therapeutics, Inc. Form D Filing — $2,000,000 | FilingFlow